Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis

J Clin Oncol. 2011 Aug 10;29(23):e678-9. doi: 10.1200/JCO.2011.35.0694. Epub 2011 Jun 20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / secondary
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Camptothecin / analogs & derivatives
  • Camptothecin / therapeutic use
  • Cetuximab
  • Colorectal Neoplasms / pathology
  • Epidermal Growth Factor / administration & dosage*
  • Female
  • Humans
  • Irinotecan
  • Keratitis / chemically induced
  • Keratitis / drug therapy*
  • Lung Neoplasms / secondary
  • Ophthalmic Solutions

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Ophthalmic Solutions
  • Epidermal Growth Factor
  • Irinotecan
  • Cetuximab
  • Camptothecin